Table 1.

Proposed strategies for clinical trials in patients with untreated advanced-stage FL

graphic
 
graphic
 

ASH, American Society of Hematology; CPC, common progenitor clone; ctDNA, circulating tumor DNA; CR30, complete response rate at 30 mo; ddPCR, digital droplet PCR; EFS12/EFS24, event-free survival at 12/24 mo; EHA, European Haematology Association; FFS, failure-free survival; FL, follicular lymphoma; NGS, next-generation sequencing; OS, overall survival; PFS, progression-free survival; POD24, progression of disease within 24 mo; QoL, quality of life.

Close Modal

or Create an Account

Close Modal
Close Modal